Methylsulfonylmethane / IL1 Cancer Research Results

MSM, Methylsulfonylmethane: Click to Expand ⟱
Features:
MSM (Methylsulfonylmethane) is a naturally occurring organosulfur compound often used as a dietary supplement for its anti-inflammatory and antioxidant effects. While most well-known for joint health.
-MSM is actually a metabolite of DMSO (dimethyl sulfoxide) 
-Generally Recognized as Safe     Possible Interactions: aspirin, warfarin, NSAIDS

-Supplement dosage: 500mg 2-3times/day


-Anti-inflammatory: ↓NF-κB, ↓COX-2 and iNOS
-↓STAT3
-↓Cyclin D1 and CDK4, halting cell cycle progression.
-↓MMP-2, MMP-9, VEGF limiting invasion.

Methylsulfonylmethane (MSM) — Cancer-Oriented Time-Scale Flagged Pathway Table
Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 NF-κB inflammatory transcription NF-κB ↓; COX-2/cytokines ↓ (reported) Inflammation tone ↓ R, G Anti-inflammatory signaling One of the most consistent findings in MSM studies is suppression of NF-κB-linked inflammatory signaling.
2 STAT3 signaling STAT3 phosphorylation ↓ (reported) ↔ R, G Pro-survival pathway suppression STAT3 inhibition has been reported in some breast and other tumor models; relevance depends on tumor type.
3 PI3K / AKT pathway AKT signaling ↓ (reported; model-dependent) ↔ R, G Growth modulation Observed in certain cell lines; should be presented as context-dependent rather than universal.
4 ROS / redox modulation ROS ↓ (often); oxidative stress tone ↓ Oxidative injury ↓ P, R, G Redox buffering MSM is generally described as anti-oxidative/anti-inflammatory rather than pro-oxidant; not a ROS-amplifying therapy.
5 Apoptosis induction Caspases ↑; Bax ↑; Bcl-2 ↓ (reported) ↔ G Cell death signaling Apoptotic effects reported in vitro; usually downstream of inflammatory and survival pathway suppression.
6 Cell-cycle regulation Cell-cycle arrest ↑ (reported) ↔ G Cytostasis Observed in some cancer cell systems; mechanism linked to signaling changes.
7 Migration / invasion (MMPs) MMP expression ↓; migration ↓ (reported) ↔ G Anti-invasive phenotype Reduction in metastasis markers reported in certain preclinical models.
8 ER stress modulation Stress signaling modulation (context-dependent) Proteostasis support R, G Stress pathway modulation Less consistent than NF-κB effects; should be kept qualified.
9 Chemo-/radiation interaction (theoretical) May reduce inflammatory toxicity; may blunt ROS-based therapies Normal tissue protection possible G Adjunct positioning Because MSM is anti-oxidative/anti-inflammatory, positioning with strong pro-oxidant therapies should be considered carefully.
10 Translation constraint Human anti-cancer efficacy not established Generally well tolerated in common supplement ranges — Evidence limitation Evidence base is largely preclinical; clinical oncology data are limited.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (NF-κB / STAT3 pathway modulation)
  • G: >3 hr (cell-cycle, apoptosis, invasion phenotype changes)


For Alzheimer's (AD):
Methylsulfonylmethane (MSM) in neurobiology is primarily framed as an anti-inflammatory and redox-buffering molecule, not a direct amyloid-clearing or tau-targeting drug. Evidence is largely preclinical (cell + animal models). Position it as a neuroinflammation and oxidative stress modulator.
-Anti-inflammatory: ↓TNF-α, IL-1β, IL-6 
-↓ROS, ↑GSH, ↓NO
-may reduce Aβ plaque burden and tau hyperphosphorylation indirectly
-improves memory in rodents

Methylsulfonylmethane (MSM) — Alzheimer’s Disease (AD) Time-Scale Flagged Pathway Table
Rank Pathway / Axis AD / Brain Context TSF Primary Effect Notes / Interpretation
1 Neuroinflammation (NF-κB / cytokine signaling) Microglial activation ↓; IL-1β/TNF-α ↓ (reported) R, G Anti-inflammatory modulation MSM’s most consistent neuro-relevant signal is suppression of NF-κB-driven inflammatory tone, which is implicated in AD progression.
2 Oxidative stress / redox buffering Lipid peroxidation ↓; ROS tone ↓ (reported) R, G Neuroprotection (stress buffering) MSM is generally described as antioxidant/anti-inflammatory rather than pro-oxidant; may help mitigate oxidative injury.
3 Mitochondrial function support Mitochondrial stress ↓ (context-dependent) R, G Bioenergetic stabilization Indirect support through reduced oxidative and inflammatory burden; not a primary mitochondrial activator.
4 ER stress / proteostasis modulation UPR signaling ↓ (reported in stress models) R, G Proteostasis buffering ER stress is relevant in AD pathology; MSM may attenuate stress signaling in some models.
5 Calcium homeostasis modulation Excitotoxic stress ↓ (indirect) P, R Signal stabilization Primarily indirect via inflammatory and oxidative stress reduction.
6 Aβ pathology (direct evidence) Limited direct evidence of amyloid reduction G Indirect modulation If effects occur, they are likely secondary to reduced oxidative stress and inflammation rather than direct amyloid targeting.
7 Tau phosphorylation Limited direct mechanistic evidence G Indirect modulation No strong mechanistic evidence that MSM directly modulates tau kinases; effects likely indirect.
8 Blood–brain barrier (BBB) considerations CNS exposure plausible but not strongly quantified R PK consideration Systemic exposure is good; CNS-specific pharmacokinetics are less clearly defined.
9 Cognitive outcome evidence Limited direct human AD trial data — Translation constraint Evidence base is largely mechanistic/preclinical; clinical AD efficacy not established.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (early redox/inflammatory signaling shifts)
  • R: 30 min–3 hr (microglial signaling + oxidative stress modulation)
  • G: >3 hr (phenotype-level neuroprotection effects)
IL1, Interleukin-1: Click to Expand ⟱
Source:
Type:
Interleukin-1 (IL-1) has long been known to be a key mediator of immunity and inflammation. Its dysregulation has been implicated in recent years in tumorigenesis and tumor progression, and its upregulation is thought to be associated with many tumors.

Interleukin-1 (IL-1) is a pro-inflammatory cytokine that plays a crucial role in the immune response and inflammation. It exists in two main forms: IL-1α and IL-1β, both of which are produced by various cell types, including macrophages, monocytes, and dendritic cells. IL-1 is involved in a wide range of biological processes, including cell proliferation, differentiation, and apoptosis.

IL-1 is often overexpressed in various cancers, including breast cancer, colorectal cancer, lung cancer, and melanoma. Its expression can be influenced by the tumor microenvironment and the presence of inflammatory cells.
Elevated levels of IL-1 are frequently associated with tumor progression and metastasis.

IL-1 is considered a pro-tumorigenic cytokine in many contexts. It can promote tumor growth by enhancing cell proliferation, survival, and angiogenesis. IL-1β, in particular, has been shown to stimulate the proliferation of cancer cells and promote the formation of new blood vessels (angiogenesis).
Scientific Papers found: Click to Expand⟱
3847- MSM,    Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement
- Review, Arthritis, NA
*Inflam↓, *Pain↓, *ROS↓, *antiOx↑, *Dose↝, *Half-Life↝, *NF-kB↓, *IL1↓, *IL6↓, *TNF-α↓, *iNOS↓, *COX2↓, *NLRP3↓, *NRF2↑, *STAT↓, *Cartilage↑, *eff↑, *eff↑, *GSH↑, *uricA↓, tumCV↓, TumCCA↑, necrosis↑, Apoptosis↑, VEGF↓, HSP90↓, IGF-1?,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Apoptosis↑, 1,   necrosis↑, 1,  

Transcription & Epigenetics ⓘ

tumCV↓, 1,  

Protein Folding & ER Stress ⓘ

HSP90↓, 1,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

IGF-1?, 1,  

Angiogenesis & Vasculature ⓘ

VEGF↓, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,   GSH↑, 1,   NRF2↑, 1,   ROS↓, 1,   uricA↓, 1,  

Cell Death ⓘ

iNOS↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

STAT↓, 1,  

Migration ⓘ

Cartilage↑, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 1,   IL1↓, 1,   IL6↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   TNF-α↓, 1,  

Protein Aggregation ⓘ

NLRP3↓, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,   eff↑, 2,   Half-Life↝, 1,  

Clinical Biomarkers ⓘ

IL6↓, 1,  

Functional Outcomes ⓘ

Pain↓, 1,  
Total Targets: 20

Scientific Paper Hit Count for: IL1, Interleukin-1
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:124  Target#:365  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

 

Home Page